Mai Adnan Gaizeh Al-Hallak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mai Adnan Gaizeh Al-Hallak has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Abeer Ahmad Aljoujou
Department of Oral Medicine, Faculty of Dentistry, University of Damascus, Damascus, Syrian Arab Republic
2 shared publications Jamileh Ali Hsaian
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Damascus, Syria
1 shared publication- Jamileh Ali Hsaian
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Damascus/Syria University, Damascus University and Yarmouk Private University, Damascus, Syria
1 shared publication - Karim Chalhoub
Faculty of Dentistry, Syrian Private University, Damascus, Syria
1 shared publication
Latest Publications
- Open Access
- 2 December 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-8
Evaluating the effectiveness of topical olive leaf extract emulgel in managing recurrent herpes labialis: a randomized controlled clinical study
Recurrent herpes labialis (RHL) is a lifelong oral health issue that affects about one-third of the world’s population, causing frequent, painful, and discomfort lesions. This randomized, triple-blinded study aimed to evaluate the effectiveness of olive leaf extract (OLE) compared to acyclovir cream (Veramid 5%) in managing vesicular stage of RHL lesions. Forty patients were randomly divided into two equal groups and were instructed to apply the prescribed medication five times a day for five consecutive days. The evaluation was carried out by measuring the pain intensity on the first day before the treatment was applied (T0), 48 h (T1), and 7 days later (T2). Additionally, the day when the pain completely healed and the day when the lesion’s crust fell off spontaneously were recorded. Statistical analysis was conducted using the Mann-Whitney test at a significance level of α = 0.05. The study results indicated that there were no significant differences in pain intensity between the two groups during the three evaluation times: T0 (P = 920), T1 (P = 0.596), and T2 (P = 1.00). Furthermore, there was no significant difference in the day when the pain was completely healed (P = 0.697). However, the OLE showed a statistically significant advantage regarding the day the lesions’ crust fell off (P = 0.040). In conclusion, OLE may be a potential alternative treatment for RHL. Trial registration: isrctn.com ID: ISRCTN87606522, 04/09/2023.
- 2 December 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-8
Open AccessEvaluating the effectiveness of topical olive leaf extract emulgel in managing recurrent herpes labialis: a randomized controlled clinical study
Recurrent herpes labialis (RHL) is a lifelong oral health issue that affects about one-third of the world’s population, causing frequent, painful, and discomfort lesions. This randomized, triple-blinded study aimed to evaluate the effectiveness of olive leaf extract (OLE) compared to acyclovir cream (Veramid 5%) in managing vesicular stage of RHL lesions. Forty patients were randomly divided into two equal groups and were instructed to apply the prescribed medication five times a day for five consecutive days. The evaluation was carried out by measuring the pain intensity on the first day before the treatment was applied (T0), 48 h (T1), and 7 days later (T2). Additionally, the day when the pain completely healed and the day when the lesion’s crust fell off spontaneously were recorded. Statistical analysis was conducted using the Mann-Whitney test at a significance level of α = 0.05. The study results indicated that there were no significant differences in pain intensity between the two groups during the three evaluation times: T0 (P = 920), T1 (P = 0.596), and T2 (P = 1.00). Furthermore, there was no significant difference in the day when the pain was completely healed (P = 0.697). However, the OLE showed a statistically significant advantage regarding the day the lesions’ crust fell off (P = 0.040). In conclusion, OLE may be a potential alternative treatment for RHL. Trial registration: isrctn.com ID: ISRCTN87606522, 04/09/2023.
- 20 February 2024
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 28 (2) , 1-6
Efficacy of photobiomodulation therapy in recurrent herpes labialis management: a randomized controlled trial
Objectives This study is aimed at assessing the therapeutic efficacy of photobiomodulation therapy (PBMT) for the management of recurrent herpes labialis (RHL) by evaluating both pain and clinical recovery. Material and methods A randomized, double-blind, controlled trial was conducted on 40 patients with RHL, and they were randomly divided into two groups, where 20 patients received treatment with PBMT (650 nm, 100 mW, 4.7 J/cm2), continuous mode, for 120 s, and placebo cream, while another 20 patients (control group) were treated with acyclovir cream 5% (5 times/5 days) and passive laser. Pain was assessed at five different times. The day when the complete disappearance of the pain was observed and the day when the crust fell off spontaneously were also recorded. Results The pain level in the control group was significantly higher than that in the PBMT group after the second application of the laser, while the differences were not significant between the two groups at other times. The pain in the PBMT group disappeared faster than that in the control group, but the difference was not significant in terms of clinical recovery. Conclusions Photobiomodulation therapy of herpes labialis reduced pain significantly faster than acyclovir, but there was no difference in healing time between the groups in light of the parameters used in this study. Clinical relevance PBMT is a promising treatment that may be an effective alternative to acyclovir in the management of recurrent herpes labialis. Trial registration isrctn.com ID: ISRCTN87606522.
- 20 February 2024
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 28 (2) , 1-6
Efficacy of photobiomodulation therapy in recurrent herpes labialis management: a randomized controlled trial
Objectives This study is aimed at assessing the therapeutic efficacy of photobiomodulation therapy (PBMT) for the management of recurrent herpes labialis (RHL) by evaluating both pain and clinical recovery. Material and methods A randomized, double-blind, controlled trial was conducted on 40 patients with RHL, and they were randomly divided into two groups, where 20 patients received treatment with PBMT (650 nm, 100 mW, 4.7 J/cm2), continuous mode, for 120 s, and placebo cream, while another 20 patients (control group) were treated with acyclovir cream 5% (5 times/5 days) and passive laser. Pain was assessed at five different times. The day when the complete disappearance of the pain was observed and the day when the crust fell off spontaneously were also recorded. Results The pain level in the control group was significantly higher than that in the PBMT group after the second application of the laser, while the differences were not significant between the two groups at other times. The pain in the PBMT group disappeared faster than that in the control group, but the difference was not significant in terms of clinical recovery. Conclusions Photobiomodulation therapy of herpes labialis reduced pain significantly faster than acyclovir, but there was no difference in healing time between the groups in light of the parameters used in this study. Clinical relevance PBMT is a promising treatment that may be an effective alternative to acyclovir in the management of recurrent herpes labialis. Trial registration isrctn.com ID: ISRCTN87606522.